McKesson Packaging Services is recalling 14,888 cartons of Diltiazem Hydrochloride Extended-Release Capsules (120 mg, 180 mg, and 240 mg strengths). This medication is being recalled because stability testing showed the drug was dissolving too quickly, which can affect how the medication is released into the body. These prescription products were distributed nationwide across the United States in 100-count bottles.
When extended-release medications dissolve too quickly (high dissolution), it can lead to 'dose dumping' where too much medicine enters the bloodstream at once, potentially causing side effects or reducing the effectiveness of the treatment over time.
Contact healthcare provider and return product to pharmacy.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.